BROOKS LABORATORIES LTD. - 533543 - Outcome of Board Meeting
Brooks Laboratories Ltd has informed BSE about Outcome of Board Meeting held on April 11, 2020.13-04-2020
13-04-2020
BROOKS LABORATORIES LTD. - 533543 - Announcement under Regulation 30 (LODR)-Allotment
Outcome of Board Meeting for allotment of Rights Equity Shares of the Company19-03-2020
BROOKS LABORATORIES LTD. - 533543 - Announcement under Regulation 30 (LODR)-Allotment
Outcome of Board Meeting for allotment of Rights Equity Shares of the Company19-03-2020
Brooks Laboratories Ltd - 533543 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of Advertisement for Extension of Rights Issue of our Company04-03-2020
Brooks Lab share price up 9% after co extends rights issue period
Shareholders will get 9 equity shares for every 20 shares held as on the record date.03-03-2020
Brooks Laboratories Ltd - 533543 - Extension Of Rights Issue Period
The Board in its meeting held on 03.03.2020 has extended the Rights Issue period from March 4, 2020 to March 12, 2020.03-03-2020
Brooks Laboratories Ltd - 533543 - Board Meeting Intimation for Review The Progress And Decide On Further Course Of Action With Respect To Ongoing Rights Issue Of The Company
BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/03/2020 ,inter alia, to consider and approve Review the progress and decide on further course of action with respect to ongoing Rights Issue of the Company02-03-2020
Brooks Laboratories Ltd - 533543 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of Rights Issue related Advertisement17-02-2020
BROOKS LABORATORIES LTD. - 533543 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Paper Publication of Unaudited Financial Results for 3rd quarter ended 31.12.201915-02-2020